These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 2184128
1. Campylobacter pylori and its role in peptic ulcer disease. Tytgat GN, Rauws EA. Gastroenterol Clin North Am; 1990 Mar; 19(1):183-96. PubMed ID: 2184128 [Abstract] [Full Text] [Related]
2. Duodenal bulb biopsy findings for patients with non-ulcer dyspepsia with or without Campylobacter pylori gastritis. Frierson HF, Caldwell SH, Marshall BJ. Mod Pathol; 1990 May; 3(3):271-6. PubMed ID: 2362937 [Abstract] [Full Text] [Related]
3. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease. Bayerdörffer E, Ottenjann R. Scand J Gastroenterol Suppl; 1988 May; 142():93-100. PubMed ID: 3047854 [Abstract] [Full Text] [Related]
4. [Therapy of peptic ulcer and chronic gastritis with bismuth salts]. Rösch W. Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149 [Abstract] [Full Text] [Related]
6. [Campylobacter pylori in patients with chronic gastritis and gastric and duodenal peptic ulcer]. Kolarski V, Tsenova V, Shopova K, Vasileva E, Petrova D. Vutr Boles; 1989 Sep; 28(2):58-62. PubMed ID: 2763525 [Abstract] [Full Text] [Related]
7. [Campylobacter pylori and late recurrences of duodenal ulcer]. Loginov AS, I'lchenko AA, Smotrova IA, Aruin LI. Klin Med (Mosk); 1989 Aug; 67(8):48-50. PubMed ID: 2811238 [No Abstract] [Full Text] [Related]
8. Campylobacter pylori. The organism and its clinical relevance. Graham DY, Evans DG, Evans DJ. J Clin Gastroenterol; 1989 Aug; 11 Suppl 1():S43-8. PubMed ID: 2809138 [Abstract] [Full Text] [Related]
9. [Is Campylobacter pylori the pathogenic agent in gastritis and peptic ulcer?]. Vráblik V, Trupl J, Pavlovic M, Horváth A, Nespor V. Vnitr Lek; 1989 Jul; 35(7):672-8. PubMed ID: 2800373 [Abstract] [Full Text] [Related]
14. [Campylobacter pylori in patients with gastroduodenal disease]. Fukuda Y, Yamamoto I, Inoue H, Mikami J, Tamura K, Satomi M, Shimoyama T. Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):575-88. PubMed ID: 2321983 [Abstract] [Full Text] [Related]
16. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN, Hahm JS, Kim HJ. Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [Abstract] [Full Text] [Related]
17. Campylobacter pylori: its role in gastritis and peptic ulcer disease. Hornick RB. Curr Clin Top Infect Dis; 1989 Dec; 10():157-73. PubMed ID: 2679692 [No Abstract] [Full Text] [Related]
18. Rationale for eradication of Helicobacter pylori infection in duodenal ulcer disease. Malfertheiner P, Domínguez-Muñoz JE. Clin Ther; 1993 Dec; 15 Suppl B():37-48. PubMed ID: 8205594 [Abstract] [Full Text] [Related]
19. Causal role of Helicobacter pylori in peptic ulcer relapse. Asaka M, Ohtaki T, Kato M, Kudo M, Kimura T, Meguro T, Horita S, Inoue K. J Gastroenterol; 1994 Jul; 29 Suppl 7():134-8. PubMed ID: 7921146 [Abstract] [Full Text] [Related]
20. [Campylobacter pylori colonization of the antrum mucosa in patients with chronic gastritis and peptic ulcer]. Brunner H, Mittermayer H, Regele H. Z Gastroenterol; 1987 Sep; 25 Suppl 4():20-3. PubMed ID: 3318189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]